The CPI Innovation Award honours the NEPIC member company or programme participant that has pursued game-changing ideas – across product, process and service – within the chemical-processing industries and associated supply chain. This Award is judged on how innovative the idea is, how the organisation adopted it and its overall business impact – coupled with clear demonstration of significant improvement in sustainability, resource utilisation, along with market entrance and business growth.
This year’s innovation award winner, FUJILFILM Diosynth Biotechnologies, have developed a ground-breaking, game changing technology that will significantly contribute to the betterment of their business and industry as a whole.
Launched in September 2019, SymphonX™ represents a disruptive approach to bioprocessing. Prior to this innovation, drug production facilities were filled with dedicated equipment designed specifically for different unit operations. SymphonX™ encompasses the functionality of all downstream process equipment in one multi-functional design – the ‘Swiss Army Knife of Biomanufacturing’ – simplifying operations.
SymphonX™ was designed and deployed in FUJIFILM’s Billingham facility for both pilot-scale and GMP manufacturing, generating drug substance for use in human clinical trials. The success triggered a global implementation programme. Twelve SymphonX™ units were built in December 2019 – all in North East, UK in collaboration with FDB’s local Automation SME partner
– with over thirty units planned by 2021.
The technology has developed five patents for FUJIFILM. In addition, business development due diligence is ongoing to explore commercial opportunities through collaboration and licensing
with an existing global industry technology vendor.
SymphonX™ was designed to reduce the risk associated with complex biologics manufacturing. The continuous mode drives the Cost of Goods associated with drug production down by 40%. It is estimated the innovation programme has also generated 15 jobs within the North East. Furthermore, SymphonX™ has attracted significant investment from FUJIFILM’s owners in Japan, investing in a $10M Continuous Biomanufacturing facility in Wilton, UK.
<< Back to Awards Home Page